Helicobacter Pylori Diagnostics Market to Grow with a CAGR of 4.31% through 2031

Rising prevalence of helicobacter pylori infections and increased awareness and screening programs are factors driving the Global Helicobacter Pylori Diagnostics Market in the forecast period 2027-2031

According to TechSci Research report, “Helicobacter Pylori Diagnostics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031”, the Global Helicobacter Pylori Diagnostics Market will grow from USD 605.78 Million in 2025 to USD 780.32 Million by 2031 at a 4.31% CAGR.

The global market for Helicobacter pylori (H. pylori) diagnostics has experienced substantial growth in recent years, driven by the increasing recognition of H. pylori as a leading cause of gastrointestinal disorders such as gastritis, peptic ulcers, and stomach cancer. With approximately 50% of the global population estimated to be infected with H. pylori, the demand for accurate diagnostic solutions has surged, fueling market expansion.

The shift from traditional, invasive diagnostic methods such as endoscopy and biopsy to more cost-effective and noninvasive options, such as serology tests, urea breath tests, and molecular diagnostics, has significantly influenced market dynamics. These advancements have made testing more accessible, reducing both patient discomfort and healthcare costs, while simultaneously driving demand for diagnostics.

Rising awareness of the health risks associated with H. pylori infections has also led to increased screening and early detection programs. Government bodies and healthcare organizations globally are prioritizing the early identification and management of H. pylori infections, recognizing the long-term benefits of reducing the incidence of related diseases. This focus on early intervention further accelerates demand for diagnostic tests.

Additionally, as the incidence of H. pylori-associated conditions such as gastritis and gastric cancer continues to rise, healthcare providers are placing greater emphasis on accurate and timely diagnosis. This shift is further contributing to market growth. Ongoing research and development efforts in the diagnostics sector are also fostering innovation, with manufacturers investing in the creation of more efficient diagnostic devices, tests, and software solutions. These innovations are improving diagnostic accuracy, ease of use, and overall effectiveness, ensuring continued expansion of the H. pylori diagnostics market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Helicobacter Pylori Diagnostics Market”

The Global Helicobacter Pylori Diagnostics Market is segmented into type, technology, end user and company.

Among end users, the Hospitals & Clinics segment has emerged as the predominant market leader. Hospitals and clinics are equipped with state-of-the-art diagnostic tools, including endoscopy, serological tests, and molecular diagnostics. These resources enable healthcare professionals to accurately detect H. pylori infection and related conditions. Hospitals and clinics often offer endoscopic examinations, which allow for direct visualization of the stomach lining and biopsy sampling, resulting in precise H. pylori detection. This method not only detects infection but also assesses the extent of tissue damage, offering vital information for treatment planning.

The Asia-Pacific region is experiencing a significant surge in H. pylori diagnostic market growth. The market’s lucrative potential has attracted the attention of both private companies and investors, resulting in a substantial influx of capital into the development, marketing, and distribution of diagnostic products. This influx of investment is not only accelerating the availability of advanced diagnostic solutions but also driving the region’s prominence as a key hub for innovation in H. pylori diagnostics.

Intense competition among local and international players has spurred technological advancements and cost reductions, ultimately resulting in more affordable and accessible diagnostic tests for healthcare providers and patients alike. As companies strive to gain a competitive edge, they are investing in research and development to develop more efficient, accurate, and user-friendly diagnostic tools, including non-invasive methods that address the growing demand for patient-centric care. This rapid market expansion in Asia Pacific is also reshaping the regional healthcare landscape. The combination of innovation and cost reduction is enhancing the accessibility of H. pylori diagnostic tests, thereby ensuring broader adoption across both developed and developing markets in the region. As the competitive environment intensifies, patients benefit from improved diagnostic options that provide faster results at lower costs, thereby contributing to better management and treatment outcomes. This dynamic growth trajectory is positioning Asia Pacific as a pivotal market in the global H. pylori diagnostics sector.

Major companies operating in Global Helicobacter Pylori Diagnostics Market are:

• Thermo Fisher Scientific inc.
• Biohit Oyj
• Quest Diagnostics Incorporated
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories Ltd
• F. Hoffmann-La Roche Ltd
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global Helicobacter Pylori diagnostics market is experiencing significant growth due to a combination of factors, including the rising prevalence of H. pylori infections, technological advancements, increased awareness, growing incidence of associated diseases, research and development efforts, expanding healthcare infrastructure, and the demand for point-of-care testing. As healthcare systems continue to evolve and emphasize early diagnosis and effective management of helicobacter pylori infections, the market is poised for further expansion in the years to come. This growth is not only beneficial for diagnostic manufacturers but also for the overall health and well-being of individuals at risk of helicobacter pylori-related diseases.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition 2021-2031F”, has evaluated the future growth potential of Global Helicobacter Pylori Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Helicobacter Pylori Diagnostics Market.

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com